2-{5-[(2S)-2-Pyrrolidinyl]-1,2,4-oxadiazol-3-yl}pyridine trifluoroacetate, 95.0%, 25g

3-((Difluoromethyl)thio)benzoic acid, 98%, 500mg

1-(2-chloro-3-methoxyphenyl)ethan-1-one, 98%, 5g

BENZYL (4-FLUOROPIPERIDIN-4-YL)METHYLCARBAMATE HCL, 90.0%, 5g

4-(3-Pyridin-3-yl-ureido)benzenesulfonyl chloridehydrogen sulfate, 1g

N-(4-((4-Chloro-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl)thio)phenyl)cyclopropanecarboxamide, 95.0%, 1g

2-Ethylhexanal>95.0%(GC)500mL

5-Fluoro-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile, 97%, 100mg

(R)-6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide, 99%, 25mg

2,6-Bis((R)-4-benzyl-4,5-dihydrooxazol-2-yl)pyridine, 95.0%, 250mg

ROTIPHORESE®10x TAE Puffer, 1 l, Glas, 1 x 1 l

Hydrazinocarbonylmethyl-carbamic acid tert-butyl ester, 95.0%, 5g

2-Hydroxypyrimidine hydrochloride, 97.0%, 10g